Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.5199
-0.0251 (-4.61%)
May 26, 2026, 2:21 PM EDT - Market open
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $11.13 million as of May 26, 2026. Its market cap has decreased by -13.67% in one year.
Market Cap
11.13M
Enterprise Value
7.99M
1-Year Change
-13.67%
Ranking
Category
Stock Price
$0.52
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $11.13M, a decrease of -66.66%. That is a compound annual growth rate of -48.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 11.67M | -21.06% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hoth Therapeutics | 13.20M |
| Moleculin Biotech | 12.75M |
| BioLineRx | 12.74M |
| Phio Pharmaceuticals | 12.66M |
| Intensity Therapeutics | 12.48M |
| BioVie | 11.46M |
| Aprea Therapeutics | 11.38M |
| Kiora Pharmaceuticals | 11.35M |